Sign inJoin waitlistJoin the waitlist

FB

Fadi Braiteh

Assistant Professor · Kirk Kerkorian School of Medicine at UNLV

Credentials: · · · ·

History

Kirk Kerkorian School of Medicine at UNLV
Present

Hematology and Medical Oncology
2006–2009
Hospice and Palliative Medicine
University of Texas M D Anderson Cancer Center
2005–2006
Family Medicine
2002–2005
Doctor of Medicine
1994–1998

Research

Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
The Lancet · 2016 · 2,381 citations
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
Nature · 2014 · 1,957 citations
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label,…
The Lancet · 2016 · 970 citations

Razelle Kurzrock
12 papers
Jeffrey Ross
6 papers
SA
Siraj Ali
6 papers
VM
Vincent Miller
6 papers
CO
Carol O'Hear
5 papers
DR
Donald Richards
5 papers
HB
Howard Burris
5 papers
DH
Daniel Von Hoff
4 papers
Michael Gordon
4 papers
NV
Nicholas Vogelzang
4 papers
SK
Samuel Klempner
4 papers
AS
Alexander Spira
3 papers

Clinical trials

Phase I Study of LB-100 With Docetaxel in Solid Tumors
Principal investigator · Completed · Phase 1
Lixte Biotechnology Holdings, Inc.
2013–2016
A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors
Principal investigator · Completed · Phase 1
Mersana Therapeutics
2011
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Site PI · Recruiting · Phase 1
NiKang Therapeutics, Inc.
2025–2027